Results 131 to 140 of about 51,688 (341)

Neuroprotective Potential of New Monoterpene-Adamatane Conjugates—A Pilot Study

Current Issues in Molecular Biology
Neurodegenerative diseases, including Alzheimer’s disease, are marked by cholinergic dysfunction, oxidative stress, and reduced neurotrophic support, which drives the quest for multifunctional therapeutic agents.
Stela Dragomanova, Polina Petkova-Kirova, Konstantin Volcho, Jóhannes Reynisson, Valya Grigorova, Diamara Uzunova, Elina Tsvetanova, Almira Georgieva, Albena Alexandrova, Miroslava Stefanova, Borislav Minchev, Jesunifemi Popoola, Nora Chouha, Aldar Munkuev, Konstantin Ponomarev, Evgenyi Suslov, Nariman Salakhutdinov, Reni Kalfin, Lyubka Tancheva   +18 more
doaj   +1 more source

Innovations in Obesity Treatment: Beyond Adipose Tissue Dysfunction

Obesity Reviews, EarlyView.
Obesity drives chronic inflammation, insulin resistance, type 2 diabetes, and cancer development through adipocyte dysfunction. Addressing this multisystemic disorder requires integrated strategies beyond diet and exercise, such as thermogenesis activation via menthol or capsinoids and appetite control through GLP‐1/GIP agonists and neuromodulation to ...
Jesica Martínez‐Godfrey, Irene Pomares‐Bri, Paula de Juan‐Maciá, Mariló Olivares‐Vicente, Enrique Barrajón‐Catalán, Vicente Micol, Enrique Roche, María Herranz‐López   +7 more
wiley   +1 more source

Effect of DM-9384, a new cognition-enhancing agent, on GABA and cholinergic systems in rat cortex

, 1990
Shigeo Watabe, Hitoshi Yamaguchi, Shin-ichiro Ashida   +2 more
openalex   +1 more source

Adverse outcomes between VMAT2 and anticholinergics in tardive dyskinesia: A target trial emulation

Psychiatry and Clinical Neurosciences, EarlyView.
Aim Vesicular monoamine transporter 2 (VMAT2) inhibitors have been approved for the treatment of tardive dyskinesia (TD), whereas anticholinergic agents are still widely used for this condition. This study aimed to compare the risk of major clinical adverse outcomes among patients with TD treated with VMAT2 inhibitors versus anticholinergic agents ...
Tien‐Wei Hsu, Chih‐Wei Hsu, Ping‐Tao Tseng, Yi‐Ya Fang, Chuo‐Yu Lee, Yu‐Hsuan Lin, Brendon Stubbs, Trevor Thompson, Andre F. Carvalho, Yu‐Chen Kao, Jen‐Ping Chen, Fu‐Chi Yang, Chia‐Kuang Tsai, Chih‐Sung Liang   +13 more
wiley   +1 more source

Cholinergic Treatments with Emphasis on M1 Muscarinic Agonists as Potential Disease-Modifying Agents for Alzheimer's Disease [PDF]

, 2008
Abraham Fisher
openalex   +1 more source

From diarrhoea to duodenal stricture: Contrast computed tomography and portal vein gas enhance disease staging

Equine Veterinary Education, EarlyView.
C. A. McKinney‐Aguirre, N. S. Browne
wiley   +1 more source

Characterizing social motivation deficits in treatment‐resistant schizophrenia: Evidence from social incentive performance

Psychiatry and Clinical Neurosciences, EarlyView.
Aim The Treatment‐Response‐and‐Resistance‐in‐Psychosis (TRRIP) criteria recognizes negative symptoms as defining features for treatment‐resistant schizophrenia (TRS). Social motivation refers to the desire to pursue social reward (and to avoid social punishment).
Simon S.Y. Lui, Jasmine W.S. Chan, Jason L.F. Chan, Kimi H.Y. Lam, Lok‐Yin Choi, Raisie W.K. Wong, Perry B.M. Leung, Na Zhan, Jason W.Y. Wong, Mindi W.Y. Chiu, Jenny P.H. Lam, Raymond C.K. Chan   +11 more
wiley   +1 more source

Pathophysiology of Alzheimer’s Disease

Journal of Ardabil University of Medical Sciences, 2017
Alzheimer's disease (AD) is a common cause of dementia in elderly people that is accompanied by progressive cognitive decline and memory loss. The pathologic hallmarks of AD are synaptic and neuronal degeneration together with extracellular senile ...
Mohammad Amani
doaj  

Phylogeny of putative cholinergic visual pathways through the pretectum to the hypothalamus in teleost fish [PDF]

, 1990
Wullimann, M., Meyer, Dietrich L., Wullimann, Mario F., Meyer, D.   +3 more
core   +1 more source

Cholinergic Supersensitivity Associated with Inferior Division Oculomotor Nerve Palsies

, 2013
We describe three patients with inferior division cranial nerve three palsy and associated supersensitivity of their mydriatic pupils to cholinergic agents.
Alan J. Franklin, MD, PhD; S. Cruz-Flores, MD; S. Chung, MD; J. Selhorst, MD
core